Journal article
The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study
Abstract
In this Viewpoint, Dr Xavier and colleagues discuss the rationale behind their choice to perform a study on a cardiovascular Polypill in the setting of primary prevention, and behind the drug combinations used in The Indian Polycap study. Results of The Indian Polycap study will be available in April 2009.
Authors
Xavier D; Pais P; Sigamani A; Pogue J; Afzal R; Yusuf S
Journal
Nature Clinical Practice Cardiovascular Medicine, Vol. 6, No. 2, pp. 96–97
Publisher
Springer Nature
Publication Date
February 2009
DOI
10.1038/ncpcardio1438
ISSN
1743-4297
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Administration, OralAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAspirinAtenololCapsulesCardiovascular AgentsCardiovascular DiseasesDiureticsDouble-Blind MethodDrug CombinationsDrug CostsHumansHydrochlorothiazideHydroxymethylglutaryl-CoA Reductase InhibitorsIndiaPlatelet Aggregation InhibitorsPrimary PreventionRamiprilResearch DesignSecondary PreventionSimvastatinTreatment Outcome